Cointime

CytoAgents

company

About

CytoAgents is a biotechnology company focused on the the treatment of COVID-19, Influenza, and other viral infectious diseases.

  • 1 - 10

Highlights

Total Funding Amount
$3.60M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$2M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation also known as cytokine storm.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$3.60M
CytoAgents has raised a total of $3.60M in funding over 2 rounds. Their latest funding was raised on Mar 10, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 10, 2021 Grant $2M 1 National Institutes of Health — Detail
May 13, 2020 Grant $1.60M 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
2
1
CytoAgents is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
เนื้อหา
บริษัท